LOMBARD MED INC's ticker is EVAR and the CUSIP is G55598109. A total of 12 filers reported holding LOMBARD MED INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 3,352,544 | $25,647,000 | 15.33% |
| Aisling Capital LLC | 886,363 | $6,820,000 | 1.32% |
| Verition Fund Management LLC | 29,097 | $224,000 | 0.03% |
| FIL Ltd | 865,980 | $6,659,000 | 0.03% |
| Alyeska Investment Group, L.P. | 104,109 | $801,000 | 0.02% |
| GLG Partners LP | 60,892 | $468,000 | 0.01% |
| MOORE CAPITAL MANAGEMENT, LP | 45,000 | $346,000 | 0.01% |
| MEYER HANDELMAN CO | 16,875 | $130,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 40,000 | $308,000,000 | 0.01% |
| Citadel Advisors | 158,175 | $1,217,000 | 0.00% |